The Evolving Tale of Immunomodulatory Drugs and Cereblon

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|5|538-541

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.5, 2014-11, pp. : 538-541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells

By Dabelic Sanja  

In Vitro Cellular & Developmental Biology - Animal, Vol. 48, Iss. 8, 2012-09 ,pp. : 518-527

Springer Publishing Company

Access to resources Recommend Favorite

Usual risk factors do not predict venous thromboembolism in newly diagnosed myeloma treated with immunomodulatory drugs

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E455-E456

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identifying the immunomodulatory components of helminths

By  

PARASITE IMMUNOLOGY (ELECTRONIC), Vol. 37, Iss. 6, 2015-06 ,pp. : 293-303

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Immunomodulatory Role of Bile Acids

By  

International Archives of Allergy and Immunology, Vol. 165, Iss. 1, 2014-09 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

An Evolving Opportunity

By  

Disaster Medicine and Public Health Preparedness, Vol. 6, Iss. 1, 2012-03 ,pp. : 8-9

Cambridge University Press

Access to resources Recommend Favorite